Nf-Ls are also released into the extracellular fluid when axons are injured or degenerate and can be measured in CSF and blood, making it a strong biomarker candidate for various neuropathological diseases, including PD (Buhmann et al., 2023; Park et al., 2024). The gene discussed is SPRED1; the disease is Parkinson disease.